Byoung Chool Suh

Title: Byoung Chool Suh: Innovator in Pharmaceutical Chemistry

Introduction

Byoung Chool Suh is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic potential. With a total of 2 patents, his work continues to influence the industry.

Latest Patents

Suh's latest patents include innovative compounds such as 4,5-diaminopyrimidine derivatives and methods for their preparation. These novel 4,5-diamino pyrimidine derivatives are described by a specific general formula, which includes various substituents that enhance their pharmaceutical properties. Additionally, he has developed cathecol derivatives that inhibit phosphodiesterase IV, showcasing a range of applications for these compounds in medicinal chemistry.

Career Highlights

Byoung Chool Suh is currently associated with Cheiljedang Corporation, where he applies his expertise in drug development. His work has been instrumental in advancing the understanding of chemical compounds that can lead to new therapeutic options. His innovative approach and dedication to research have positioned him as a key figure in his field.

Collaborations

Throughout his career, Suh has collaborated with notable colleagues, including Myung Xik Xiang and Chung Keun Rhee. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

Byoung Chool Suh's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His ongoing work continues to pave the way for advancements in drug development and therapeutic solutions.